Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Imfinzi Approved in US for Less-Frequent, Fixed-Dose Use

americanpharmaceuticalreviewDecember 08, 2020

Tag: Imfinzi , NSCLC , AstraZeneca , cancer

PharmaSources Customer Service